←Back to Expert Scholars
Translational Medicine / 转化医学HER2 Ultra-Low
Erika Hamilton
MD
🏢Sarah Cannon Research Institute🌐USA
Director, Breast Cancer Research Program
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Erika Hamilton directs breast cancer research at Sarah Cannon and contributes to multiple HER2 ADC trials. Her work spans first-in-human through registration studies for HER2-low and ultra-low disease. She has helped expand HER2 therapy options in community-connected academic settings.
Share:
🧪Research Fields 研究领域
Early-phase trials
ADCs
HER2 therapy
Triple-negative breast cancer
Translational trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Erika Hamilton 的研究动态
Follow Erika Hamilton's research updates
留下邮箱，当我们发布与 Erika Hamilton（Sarah Cannon Research Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment